These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30013366)

  • 1. Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression.
    Zhang H; Lian Z; Sun G; Liu R; Xu Y
    Onco Targets Ther; 2018; 11():3853-3867. PubMed ID: 30013366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-516a-3p promotes proliferation, migration, and invasion and inhibits apoptosis in lung adenocarcinoma by targeting PTPRD.
    Wu A; Yang X; Zhang B; Wang S; Li G
    Int J Clin Exp Pathol; 2019; 12(11):4222-4231. PubMed ID: 31933822
    [No Abstract]   [Full Text] [Related]  

  • 3. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
    Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
    Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.
    Guo J; Wang M; Liu X
    J Exp Clin Cancer Res; 2015 Sep; 34(1):91. PubMed ID: 26338045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling.
    Wa Q; Zou C; Lin Z; Huang S; Peng X; Yang C; Ren D; Xu D; Guo Y; Liao Z; Wang B; Hu H; Huang S; He P
    Mol Ther Oncolytics; 2020 Jun; 17():267-277. PubMed ID: 32368615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
    Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of microRNA-92b-3p predicts survival outcomes of patients with prostate cancer and functions as an oncogene in tumor progression.
    Wang G; Cheng B; Jia R; Tan B; Liu W
    Oncol Lett; 2021 Jan; 21(1):4. PubMed ID: 33240410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression.
    Epis MR; Giles KM; Beveridge DJ; Richardson KL; Candy PA; Stuart LM; Bentel J; Cohen RJ; Leedman PJ
    Oncotarget; 2017 Aug; 8(33):55116-55134. PubMed ID: 28903407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
    Feng Q; He P; Wang Y
    Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
    Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y
    Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling.
    Liu JZ; Yin FY; Yan CY; Wang H; Luo XH
    Urology; 2017 Jul; 105():208.e11-208.e17. PubMed ID: 28088556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of miR-103a-3p Targeted Regulation of TRIM66 Axis on Docetaxel Resistance and Glycolysis in Prostate Cancer Cells.
    Yi Q; Wei J; Li Y
    Front Genet; 2021; 12():813793. PubMed ID: 35211152
    [No Abstract]   [Full Text] [Related]  

  • 15. MiR-142-3p functions as an oncogene in prostate cancer by targeting FOXO1.
    Tan YF; Chen ZY; Wang L; Wang M; Liu XH
    J Cancer; 2020; 11(6):1614-1624. PubMed ID: 32047567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
    Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A.
    Ye XY; Xu L; Lu S; Chen ZW
    Int J Immunopathol Pharmacol; 2019; 33():2058738419841481. PubMed ID: 30966836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
    Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
    Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.
    Qu F; Zheng J; Gan W; Lian H; He H; Li W; Yuan T; Yang Y; Li X; Ji C; Yan X; Xu L; Guo H
    Oncotarget; 2017 Aug; 8(32):52465-52473. PubMed ID: 28881744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling.
    Huang S; Zou C; Tang Y; Wa Q; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou X; Pan J
    Mol Ther Nucleic Acids; 2019 Jun; 16():91-104. PubMed ID: 30852380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.